Attached files

file filename
8-K - IASIS HEALTHCARE LLC 8-K - IASIS Healthcare LLCa6603915.htm

Exhibit 99.1

IASIS Healthcare Announces First Quarter 2011 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--February 9, 2011--IASIS Healthcare® LLC (“IASIS”) today announced financial and operating results for the fiscal first quarter ended December 31, 2010.

Net revenue for the first quarter totaled $673.3 million, an increase of 7.1%, compared to $629.0 million in the prior year quarter. Adjusted EBITDA for the first quarter totaled $68.2 million, compared to $71.8 million in the prior year quarter. Impacting adjusted EBITDA in the first quarter is $1.4 million in severance-related costs associated with the transition of the Company’s executive management team and $1.7 million in one-time settlement cost related to a terminated contract. Net earnings from continuing operations for the first quarter totaled $16.7 million, compared to $19.3 million in the prior year quarter.

In the first quarter, admissions and adjusted admissions increased 3.8% and 7.7%, respectively, compared to the prior year quarter. Net patient revenue per adjusted admission increased 3.0% in the first quarter, compared to the prior year quarter. On a same-facility basis, admissions and adjusted admissions decreased 4.4% and 1.5%, respectively. Excluding the closure of an obstetrics unit at one of the Company’s hospitals, same-facility admissions decreased 3.0%, while same-facility adjusted admissions were flat, compared to the prior year quarter.

“While we continue to operate in a challenging economic and state budgetary environment, we are excited about the future of our company,” said W. Carl Whitmer, president and chief executive officer of IASIS Healthcare. “Our operational and developmental initiatives are designed to capitalize on a changing healthcare marketplace. During the previous quarter, we welcomed our new chief operating officer and continued our focus on physician alignment and other business development opportunities. We believe that our strategic initiatives and commitment to providing healthcare services of the highest quality will result in continued growth and financial strength.”

A listen-only simulcast and 30-day replay of IASIS’ first quarter conference call will be available by clicking the “For Investors” link on the Company’s Web site at www.iasishealthcare.com beginning at 11:00 a.m. Eastern Time on February 9, 2011. A copy of this press release will also be available on the Company’s Web site.


IASIS, located in Franklin, Tennessee, is a leading owner and operator of medium-sized acute care hospitals in high-growth urban and suburban markets. The Company operates its hospitals with a strong community focus by offering and developing healthcare services targeted to the needs of the markets it serves, promoting strong relationships with physicians and working with local managed care plans. IASIS owns or leases 17 acute care hospital facilities and one behavioral health hospital facility with a total of 3,570 licensed beds and has total annual net revenue of approximately $2.6 billion. These hospital facilities are located in seven regions: Salt Lake City, Utah; Phoenix, Arizona; Tampa-St. Petersburg, Florida; four cities in Texas, including San Antonio; Las Vegas, Nevada; West Monroe, Louisiana; and Woodland Park, Colorado. IASIS also owns and operates a Medicaid and Medicare managed health plan in Phoenix that serves more than 197,000 members. For more information on IASIS, please visit the Company’s Web site at www.iasishealthcare.com.

Some of the statements we make in this press release are forward-looking within the meaning of the federal securities laws, which are intended to be covered by the safe harbors created thereby. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations including, but not limited to, future financial and operating results, the Company’s plans, objectives, expectations and other statements that are not historical facts. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results in future periods to differ materially from those anticipated in the forward-looking statements. These risk factors and uncertainties are more fully described in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010, and other filings with the Securities and Exchange Commission.

Although we believe that the assumptions underlying the forward-looking statements contained in this press release are reasonable, any of these assumptions could prove to be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, you should not regard the inclusion of such information as a representation by the Company or any other person that our objectives and plans will be achieved. We undertake no obligation to publicly release any revisions to any forward-looking statements contained herein to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.

Adjusted EBITDA represents net earnings from continuing operations before interest expense, income tax expense, depreciation and amortization, stock compensation, gain on disposal of assets and management fees. Management fees represent monitoring and advisory fees paid to TPG, the Company’s majority financial sponsor, and certain other members of IASIS Investment LLC. Management routinely calculates and communicates adjusted EBITDA and believes that it is useful to investors because it is commonly used as an analytical indicator within the healthcare industry to evaluate hospital performance, allocate resources and measure leverage capacity and debt service ability. In addition, the Company uses adjusted EBITDA as a measure of performance for its business segments and for incentive compensation purposes. Adjusted EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net earnings, cash flows generated by operating, investing, or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. Adjusted EBITDA, as presented, differs from what is defined under the Company’s senior secured credit facilities and may not be comparable to similarly titled measures of other companies. A table describing adjusted EBITDA and reconciling net earnings from continuing operations to adjusted EBITDA is included in this press release in the attached Supplemental Consolidated Statements of Operations Information.


IASIS HEALTHCARE LLC

Consolidated Statements of Operations (Unaudited)

(in thousands)

  Quarter Ended

December 31,

  2010       2009  
Net revenue:
Acute care revenue $ 471,139 $ 424,660
Premium revenue   202,192     204,297  
Total net revenue 673,331 628,957
 
Costs and expenses:

Salaries and benefits (includes stock compensation of $496 and $121, respectively)

 

189,913

170,482

Supplies 76,436 65,409
Medical claims 171,334 178,567
Other operating expenses 97,126 84,592
Provision for bad debts 59,614 47,949
Rentals and leases 11,166 10,275
Interest expense, net 16,877 16,732
Depreciation and amortization 24,046 23,877
Management fees   1,250     1,250  
Total costs and expenses 647,762 599,133
 
Earnings from continuing operations before gain on disposal

of assets and income taxes

25,569 29,824
Gain on disposal of assets, net   345     104  
 
Earnings from continuing operations before income taxes 25,914 29,928
Income tax expense   9,189     10,591  
 
Net earnings from continuing operations 16,725 19,337
Earnings (loss) from discontinued operations, net of income taxes   (3,208 )   46  
 
Net earnings 13,517 19,383
Net earnings attributable to non-controlling interests   (1,771 )   (2,028 )
 
Net earnings attributable to IASIS Healthcare LLC $ 11,746   $ 17,355  

IASIS HEALTHCARE LLC

Consolidated Balance Sheets (Unaudited)

(in thousands)

   
Dec. 31,

2010

Sept. 30,

2010

 
ASSETS
 
Current assets:
Cash and cash equivalents $ 129,246 $ 144,511
Accounts receivable, net 236,094 209,173
Inventories 59,081 53,842
Deferred income taxes 24,854 15,881
Prepaid expenses and other current assets 71,821 65,340
Total current assets 521,096 488,747
 
Property and equipment, net 997,767 985,291
Goodwill 798,394 718,243
Other intangible assets, net 33,434 27,000
Deposit for acquisition 97,891
Other assets, net 35,691 36,022
Total assets $ 2,386,382 $ 2,353,194
 
LIABILITIES AND EQUITY
 
Current liabilities:
Accounts payable $ 77,989 $ 78,931
Salaries and benefits payable 35,580 38,110
Accrued interest payable 2,108 12,536
Medical claims payable 116,457 111,373
Other accrued expenses and other current liabilities 100,261 106,614
Current portion of long-term debt and capital lease obligations 7,693 6,691
Total current liabilities 340,088 354,255
 
Long-term debt and capital lease obligations 1,049,660 1,044,887
Deferred income taxes 108,566 109,272
Other long-term liabilities 64,317 60,162
 
Non-controlling interests with redemption rights 88,433 72,112
 
Equity:
Member’s equity 725,056 702,135
Non-controlling interests 10,262 10,371
Total equity 735,318 712,506
Total liabilities and equity $ 2,386,382 $ 2,353,194

IASIS HEALTHCARE LLC

Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

 
Quarter Ended

December 31,

  2010       2009  
Cash flows from operating activities:
Net earnings $ 13,517 $ 19,383
Adjustments to reconcile net earnings to net cash provided by

operating activities:

Loss (earnings) from discontinued operations 3,208 (46 )
Depreciation and amortization 24,046 23,877
Amortization of loan costs 810 775
Deferred income taxes 2,539 2,652
Income tax benefit from parent company interest 2,240 2,224
Gain on disposal of assets, net (345 ) (104 )
Stock compensation costs 496 121
Changes in operating assets and liabilities, net of the effect

of acquisitions and dispositions:

Accounts receivable, net (8,334 ) (4,332 )
Inventories, prepaid expenses and other current assets (5,956 ) 4,486
Accounts payable, other accrued expenses and other accrued liabilities   (25,499 )   (39,373 )
Net cash provided by operating activities – continuing operations 6,722 9,663
Net cash used in operating activities – discontinued operations   (240 )   (125 )
Net cash provided by operating activities   6,482     9,538  
 
Cash flows from investing activities:
Purchases of property and equipment, net (15,360 ) (12,282 )
Cash paid for acquisitions, net (1,880 )
Proceeds from sale of assets 31
Change in other assets, net   515     659  
Net cash used in investing activities   (16,725 )   (11,592 )
 
Cash flows from financing activities:
Payment of debt and capital lease obligations (1,933 ) (3,452 )
Distributions to non-controlling interests (3,089 ) (3,934 )
Costs paid for the repurchase of non-controlling interests, net       (13 )
Net cash used in financing activities   (5,022 )   (7,399 )
 
Change in cash and cash equivalents (15,265 ) (9,453 )
Cash and cash equivalents at beginning of period   144,511     206,528  
Cash and cash equivalents at end of period $ 129,246   $ 197,075  
 
Supplemental disclosure of cash flow information:
Cash paid for interest $ 26,514   $ 26,393  
Cash paid for income taxes, net $ 5   $ 4,000  

IASIS HEALTHCARE LLC

Segment Information (Unaudited)

(in thousands)

 
For the Quarter Ended December 31, 2010
Acute Care   Health Choice   Eliminations   Consolidated
Acute care revenue $ 471,139 $ $ $ 471,139
Premium revenue 202,192 202,192
Revenue between segments   2,660     (2,660 )  
Net revenue 473,799 202,192 (2,660 ) 673,331
 

Salaries and benefits (excludes stock compensation)

 

184,394

5,023 189,417
Supplies 76,392 44 76,436
Medical claims 173,994 (2,660 ) 171,334
Other operating expenses 90,830 6,296 97,126
Provision for bad debts 59,614 59,614
Rentals and leases   10,722   444       11,166
Adjusted EBITDA 51,847 16,391 68,238
 
Interest expense, net 16,877 16,877
Depreciation and amortization 23,151 895 24,046
Stock compensation 496 496
Management fees   1,250         1,250
Earnings from continuing operations before gain on disposal of assets and income taxes 10,073 15,496 25,569
Gain on disposal of assets, net   345         345

Earnings from continuing operations before income taxes

 

$ 10,418 $ 15,496 $   $ 25,914
  For the Quarter Ended December 31, 2009
Acute Care   Health Choice   Eliminations   Consolidated
Acute care revenue $ 424,660 $ $ $ 424,660
Premium revenue 204,297 204,297
Revenue between segments   2,676     (2,676 )  
Net revenue 427,336 204,297 (2,676 ) 628,957
 

Salaries and benefits (excludes stock compensation)

 

165,769 4,592 170,361
Supplies 65,362 47 65,409
Medical claims 181,243 (2,676 ) 178,567
Other operating expenses 78,325 6,267 84,592
Provision for bad debts 47,949 47,949
Rentals and leases   9,904   371       10,275
Adjusted EBITDA 60,027 11,777 71,804
 
Interest expense, net 16,732 16,732
Depreciation and amortization 22,988 889 23,877
Stock compensation 121 121
Management fees   1,250         1,250
Earnings from continuing operations before gain on disposal of assets and income taxes 18,936 10,888 29,824
Gain on disposal of assets, net   104         104

Earnings from continuing operations before income taxes

 

$ 19,040 $ 10,888 $   $ 29,928

IASIS HEALTHCARE LLC

Consolidated Financial and Operating Data (Unaudited)

 
Quarter Ended

December 31,

2010     2009  
Consolidated Hospital Facilities (1)
Number of acute care hospital facilities at end of period 17 15
Licensed beds at end of period 3,570 3,185
Average length of stay (days) 4.9 4.8
Occupancy rates (average beds in service) 45.3 % 45.4 %
Admissions 26,202 25,253
Percentage change 3.8 %
Adjusted admissions 45,312 42,067
Percentage change 7.7 %
Patient days 127,807 120,551
Adjusted patient days 211,696 193,223
Outpatient revenue as a % of gross patient revenue 41.0 % 39.0 %
 

Same-Facility Hospitals (2)

Number of acute care hospital facilities at end of period 15 15
Licensed beds at end of period 3,185 3,185
Average length of stay (days) 4.9 4.8
Occupancy rates (average beds in service) 44.8 % 45.4 %
Admissions 24,137 25,253
Percentage change (4.4 )%
Adjusted admissions 41,436 42,067
Percentage change (1.5 )%
Patient days 119,284 120,551
Adjusted patient days 196,045 193,223
Outpatient revenue as a % of gross patient revenue 40.7 % 39.0 %
 

(1)  Includes the hospitals acquired in the acquisition of Brim Holdings, Inc. (“Brim”), which was effective October 1, 2010.

(2)  Excludes the impact of the Brim acquisition.


IASIS HEALTHCARE LLC

Supplemental Consolidated Statements of Operations Information (Unaudited)

(in thousands)

 
Quarter Ended

December 31,

  2010       2009  
Consolidated Results
Net earnings from continuing operations $ 16,725 $ 19,337
Add:
Interest expense, net 16,877 16,732
Income tax expense 9,189 10,591
Depreciation and amortization 24,046 23,877
Stock compensation 496 121
Gain on disposal of assets, net (345 ) (104 )
Management fees   1,250     1,250  
Adjusted EBITDA $ 68,238   $ 71,804  

CONTACT:
IASIS Healthcare LLC
Investor Contact:
W. Carl Whitmer, 615-844-2747
President and Chief Executive Officer
or
John M. Doyle, 615-844-2747
Chief Financial Officer
or
Media Contact:
Michele M. Peden, 615-467-1255
VP, Corporate Communications